• Molecular NameOxytetracycline
  • SynonymNA
  • Weight460.439
  • Drugbank_IDDB00595
  • ACS_NO79-57-2
  • Show 3D model
  • LogP (experiment)-1.12
  • LogP (predicted, AB/LogP v2.0)-1.49
  • pka3.3, 7.3, 9.1 (25°).
  • LogD (pH=7, predicted)-4.27
  • Solubility (experiment)0.334
  • LogS (predicted, ACD/Labs)(ph=7)-2.31
  • LogSw (predicted, AB/LogsW2.0)2.8
  • Sw (mg/ml) (predicted, ACD/Labs)0.47
  • No.of HBond Donors8
  • No.of HBond Acceptors11
  • No.of Rotatable Bonds2
  • TPSA201.85
  • StatusFDA approved
  • AdministrationOral, Ophthalmic
  • PharmacologyThe second of the broad-spectrum tetracycline group of antibiotics to be discovered.
  • Absorption_value58.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability58.0
  • Protein binding27.5
  • Volume of distribution (VD)0.42~1.08 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifePlasma half-life, about 9 h, increased in renal impairment.
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A